Lasa Supergenerics Limited (LASA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Lasa Supergenerics Limited (LASA) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.59 Million ≈ $27.98K USD) by net assets (Rs563.42 Million ≈ $6.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Lasa Supergenerics Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Lasa Supergenerics Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Lasa Supergenerics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lasa Supergenerics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lasa Supergenerics Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ABM International Limited NSE:ABMINTLLTD	0.002x
Gold Basin Resources Corp V:GXX	0.026x
Beston Global Food Company Ltd AU:BFC	-1.028x
Kuke Music Holding Ltd NYSE:KUKE	-0.498x
ADDvise Group AB A ST:ADDV-A	0.049x
Redhill Biopharma Ltd NASDAQ:RDHL	-0.588x
Algorhythm Holdings, Inc. NASDAQ:RIME	10.930x
Indo Komoditi Korpora Tbk PT JK:INCF	0.024x

Annual Cash Flow Conversion Efficiency for Lasa Supergenerics Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Lasa Supergenerics Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Lasa Supergenerics Limited (LASA) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs837.13 Million ≈ $9.05 Million	Rs-28.24 Million ≈ $-305.37K	-0.034x	-252.47%
2024-03-31	Rs966.76 Million ≈ $10.46 Million	Rs21.39 Million ≈ $231.29K	0.022x	+115.13%
2023-03-31	Rs1.18 Billion ≈ $12.79 Million	Rs-173.00 Million ≈ $-1.87 Million	-0.146x	-350.68%
2022-03-31	Rs1.58 Billion ≈ $17.07 Million	Rs92.12 Million ≈ $996.20K	0.058x	-77.56%
2021-03-31	Rs1.59 Billion ≈ $17.19 Million	Rs413.10 Million ≈ $4.47 Million	0.260x	+169.95%
2020-03-31	Rs1.41 Billion ≈ $15.30 Million	Rs136.23 Million ≈ $1.47 Million	0.096x	-75.06%
2019-03-31	Rs1.05 Billion ≈ $11.39 Million	Rs406.58 Million ≈ $4.40 Million	0.386x	+12.48%
2018-03-31	Rs1.17 Billion ≈ $12.69 Million	Rs402.80 Million ≈ $4.36 Million	0.343x	+962.97%
2017-03-31	Rs754.94 Million ≈ $8.16 Million	Rs-30.03 Million ≈ $-324.76K	-0.040x	--

About Lasa Supergenerics Limited

NSE:LASA India Drug Manufacturers - Specialty & Generic

Market Cap

$4.23 Million

Rs391.29 Million INR

Market Cap Rank

#28870 Global

#1612 in India

Share Price

Rs7.81

Change (1 day)

+2.76%

52-Week Range

Rs5.67 - Rs13.92

All Time High

Rs206.80